Interestingly, miRNA-200c was also studied in leiomyosarcoma (LMS), where its progressive decline of expression altered the transcriptional regulation of genes controlling the NF-κB pathway, inflammation and cell cycle [105]. This evidence concerns the gene NFKB1 and leiomyosarcoma.